Literature DB >> 17573785

Fate of five celiac disease-associated antibodies during normal diet in genetically at-risk children observed from birth in a natural history study.

Satu Simell1, Sanna Hoppu, Anne Hekkala, Tuula Simell, Marja-Riitta Ståhlberg, Markku Viander, Heta Yrjänäinen, Juhani Grönlund, Perttu Markula, Ville Simell, Mikael Knip, Jorma Ilonen, Heikki Hyöty, Olli Simell.   

Abstract

OBJECTIVES: To explore the natural history of antibodies against tissue transglutaminase (TGA), endomysium (EMA), reticulin (ARA), and gliadin (AGA-IgG and AGA-IgA) in children carrying HLA-conferred risk for celiac disease (CD) and observed frequently from birth.
METHODS: TGA was measured in serum samples obtained between years 2000 and 2003 from 1,320 children carrying genetic CD risk. If a sample was TGA positive, all five antibodies were analyzed in all banked and forthcoming samples from that child, and a duodenal biopsy was recommended. At the end of this observation, in August 2004, the age of the children was from 1 to 9.5 yr (mean 4.1 yr).
RESULTS: Forty-nine children (3.7%) were TGA positive. In these children, AGA-IgG had emerged at the mean age (+/- SD, range) of 2.0 +/- 1.5, 0.5-6.6 yr, while TGA, EMA, and ARA all emerged concurrently somewhat later (TGA at 3.2 +/- 1.5, 1.0-7.0 yr, P < 0.001 when compared to AGA-IgG). Despite continuing gluten exposure, positive TGA, EMA, ARA, AGA-IgA, and AGA-IgG values were spontaneously lost in 49%, 45%, 43%, 41%, and 32% of the children, respectively. CD was diagnosed by biopsy in 20 of the 26 TGA-positive children who consented to a biopsy.
CONCLUSIONS: Potential CD trigger(s) other than only gluten probably function before AGA-IgG emerges, i.e., > or =3 months earlier than the transglutaminase-associated antibodies appear. In a remarkable proportion of the children, antibodies disappear spontaneously suggesting that regulatory immune phenomena under favorable circumstances are able to extinguish incipient CD in genetically at-risk children even without exclusion of gluten from the diet.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17573785     DOI: 10.1111/j.1572-0241.2007.01360.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  20 in total

Review 1.  Translational mini-review series on the immunogenetics of gut disease: immunogenetics of coeliac disease.

Authors:  P C Dubois; D A van Heel
Journal:  Clin Exp Immunol       Date:  2008-08       Impact factor: 4.330

2.  Recent advances in celiac disease.

Authors:  Hugh James Freeman; Angeli Chopra; Michael Tom Clandinin; Alan Br Thomson
Journal:  World J Gastroenterol       Date:  2011-05-14       Impact factor: 5.742

Review 3.  Testing for antireticulin antibodies in patients with celiac disease is obsolete: a review of recommendations for serologic screening and the literature.

Authors:  Sarada L Nandiwada; Anne E Tebo
Journal:  Clin Vaccine Immunol       Date:  2013-01-30

Review 4.  The diagnosis and treatment of celiac disease.

Authors:  Detlef Schuppan; Klaus-Peter Zimmer
Journal:  Dtsch Arztebl Int       Date:  2013-12-06       Impact factor: 5.594

5.  Natural history and clinical detection of undiagnosed coeliac disease in a North American community.

Authors:  I A Hujoel; C T Van Dyke; T Brantner; J Larson; K S King; A Sharma; J A Murray; A Rubio-Tapia
Journal:  Aliment Pharmacol Ther       Date:  2018-03-25       Impact factor: 8.171

6.  Red cell distribution width can predict intestinal atrophy in selected patients with celiac disease.

Authors:  Ozgur Harmanci; Taylan Kav; Bulent Sivri
Journal:  J Clin Lab Anal       Date:  2012-11       Impact factor: 2.352

7.  Reovirus infection triggers inflammatory responses to dietary antigens and development of celiac disease.

Authors:  Romain Bouziat; Reinhard Hinterleitner; Judy J Brown; Jennifer E Stencel-Baerenwald; Mine Ikizler; Toufic Mayassi; Marlies Meisel; Sangman M Kim; Valentina Discepolo; Andrea J Pruijssers; Jordan D Ernest; Jason A Iskarpatyoti; Léa M M Costes; Ian Lawrence; Brad A Palanski; Mukund Varma; Matthew A Zurenski; Solomiia Khomandiak; Nicole McAllister; Pavithra Aravamudhan; Karl W Boehme; Fengling Hu; Janneke N Samsom; Hans-Christian Reinecker; Sonia S Kupfer; Stefano Guandalini; Carol E Semrad; Valérie Abadie; Chaitan Khosla; Luis B Barreiro; Ramnik J Xavier; Aylwin Ng; Terence S Dermody; Bana Jabri
Journal:  Science       Date:  2017-04-07       Impact factor: 47.728

8.  Spontaneous normalization of anti-tissue transglutaminase antibody levels is common in children with type 1 diabetes mellitus.

Authors:  Orith Waisbourd-Zinman; Iva Hojsak; Yoram Rosenbach; Yael Mozer-Glassberg; Shlomit Shalitin; Moshe Phillip; Raanan Shamir
Journal:  Dig Dis Sci       Date:  2011-12-16       Impact factor: 3.199

9.  Adult celiac disease and its malignant complications.

Authors:  Hugh J Freeman
Journal:  Gut Liver       Date:  2009-12-31       Impact factor: 4.519

10.  Age at development of type 1 diabetes- and celiac disease-associated antibodies and clinical disease in genetically susceptible children observed from birth.

Authors:  Satu Simell; Sanna Hoppu; Tuu Simell; Marja-Riitta Ståhlberg; Markku Viander; Taina Routi; Ville Simell; Riitta Veijola; Jorma Ilonen; Heikki Hyöty; Mikael Knip; Olli Simell
Journal:  Diabetes Care       Date:  2010-01-07       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.